Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells.
- F. Tabet, K. Vickers, +11 authors Kerry-Anne Rye
- Chemistry, Medicine
- Nature communications
- 28 February 2014
High-density lipoproteins (HDL) have many biological functions, including reducing endothelial activation and adhesion molecule expression. We recently reported that HDL transport and deliver… Expand
The PCSK9 decade
- G. Lambert, B. Sjouke, B. Choque, J. Kastelein, G. Hovingh
- Biology, Medicine
- Journal of Lipid Research
- 1 December 2012
PCSK9 proprotein convertase subtilisin/kexin type (PCSK9) is a crucial protein in LDL cholesterol (LDL-C) metabolism by virtue of its pivotal role in the degradation of the LDL receptor. In recent… Expand
Cardiac sympathetic nerve function in congestive heart failure.
- G. Eisenhofer, P. Friberg, +6 authors M. Esler
- Medicine
- Circulation
- 1 May 1996
BACKGROUND
Increased availability of norepinephrine (NE) for activation of cardiac adrenoceptors (increased cardiac adrenergic drive) and depletion of myocardial NE stores may contribute to the… Expand
Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I
- E. Nobécourt, F. Tabet, +11 authors Kerry-Anne Rye
- Chemistry, Medicine
- Arteriosclerosis, thrombosis, and vascular…
- 1 April 2010
Objective—The goal of this study was to investigate the effects of nonenzymatic glycation on the antiinflammatory properties of apolipoprotein (apo) A-I. Methods and Results—Rabbits were infused with… Expand
Increased sympathetic nerve activity in renovascular hypertension.
- M. Johansson, M. Elam, +4 authors P. Friberg
- Medicine
- Circulation
- 18 May 1999
BACKGROUND
Increased sympathetic nerve activity may contribute to the progression of renovascular hypertension. Because previous results have been inconclusive, we investigated whether renovascular… Expand
Hepatocyte nuclear factor 4&agr; in the intestinal epithelial cells protects against inflammatory bowel disease
Background: Hepatocyte nuclear factor 4&agr; (HNF4&agr;; NR2A1) is an orphan member of the nuclear receptor superfamily expressed in liver and intestine. While HNF4&agr; expression is critical for… Expand
Unravelling the functional significance of PCSK9
- G. Lambert
- Biology, Medicine
- Current opinion in lipidology
- 1 June 2007
Purpose of review Proprotein convertase subtilisin kexin type 9 (PCSK9) has emerged as a potential target for lowering plasma LDL cholesterol levels. This review summarizes recent studies published… Expand
PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.
- R. Alonso, P. Mata, +9 authors G. Lambert
- Medicine
- Atherosclerosis
- 1 November 2016
BACKGROUND AND AIMS
We aimed to assess whether elevated PCSK9 and lipoprotein (a) [Lp(a)] levels associate with coronary artery calcification (CAC), a good marker of atherosclerosis burden, in… Expand
Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment.
- G. Lambert, N. Ancellin, +8 authors P. Barter
- Chemistry, Medicine
- Clinical chemistry
- 1 June 2008
BACKGROUND
Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes the degradation of the LDL receptor (LDLr) in hepatocytes, and its expression in mouse liver has been shown to decrease with… Expand
Molecular basis of PCSK9 function.
- G. Lambert, F. Charlton, Kerry-Anne Rye, D. Piper
- Biology, Medicine
- Atherosclerosis
- 1 March 2009
The LDL receptor (LDLr) inhibitor Proprotein Convertase Subtilisin Kexin type 9 (PCSK9) has emerged as a genetically validated target for lowering plasma LDL cholesterol levels. In 2007, PCSK9 was… Expand